Annual report [Section 13 and 15(d), not S-K Item 405]

Stock-Based Compensation

v3.25.3
Stock-Based Compensation
12 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Stock-Based Compensation
Note 13:    Stock-Based Compensation
From time to time, the Company grants stock options and restricted stock awards to directors, officers, and employees. These awards are valued at the grant date by determining the fair value of the instruments. The value of each award is amortized on a straight-line basis over the requisite service period.
Stock Options
The following table summarizes stock option activity for the years ended September 30, 2025 and 2024:
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life
Intrinsic
Value
Outstanding at September 30, 2023 53,750 $ 21.51  1.54 $ 540 
Granted 17,500 40.00   
Exercised (6,250) 15.00   
Forfeited (5,000) 40.00   
Outstanding at September 30, 2024 60,000 $ 26.04  1.29 $ 130 
Exercisable at September 30, 2024 60,000 $ 26.04  1.29 $ 130 
   
Outstanding at September 30, 2024 60,000 $ 26.04  1.29 $ 130 
Forfeited (60,000) 26.04   
Outstanding at September 30, 2025 0 $ —  0 $ — 
Exercisable at September 30, 2025 0 $ —  0 $ — 
The Company recognized compensation expense of approximately $200,000 and $325,000 during the years ended September 30, 2025 and 2024, respectively, related to stock option awards and restricted stock awards granted to certain employees and officers based on the grant date fair value of the awards. No forfeitures are estimated. During the years ended September 30, 2025 and 2024, 0 and 17,500 stock options were granted, respectively. During the years ended September 30, 2025 and 2024, no restricted stock awards were granted.
At September 30, 2025 the Company had approximately $0.5 million of unrecognized compensation expense associated with restricted stock awards.